![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
COVID-19: Daily Top 10 Papers |
Ovarian Neoplasms |
Free Subscription
2 Am J Obstet Gynecol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
The Impact of Opportunistic Salpingectomy on Ovarian Cancer Mortality and
Healthcare Costs: A Call For Universal Insurance Coverage.
Am J Obstet Gynecol. 2021 Mar 30. pii: S0002-9378(21)00212.
PubMed
Abstract available
Prognostic impact of hysteroscopic resection of endometrial atypical
hyperplasia/endometrioid intraepithelial neoplasia and early-stage cancer in
combination with megestrol acetate.
Am J Obstet Gynecol. 2020 Dec 29. pii: S0002-9378(20)32627.
PubMed
Abstract available
Factors determining ultra-short-term survival and the commencement of active
treatment in high-grade serous ovarian cancer: a case comparison study.
BMC Cancer. 2021;21:378.
PubMed
Abstract available
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients
with selected solid tumours.
Br J Cancer. 2020;123:1730-1736.
PubMed
Abstract available
Mutational profile of endometrial hyperplasia and risk of progression to
endometrioid adenocarcinoma.
Cancer. 2020 Mar 18. doi: 10.1002/cncr.32822.
PubMed
Abstract available
Mesothelin-specific CAR T cells target ovarian cancer.
Cancer Res. 2021 Apr 1. pii: 0008-5472.CAN-20-2701.
PubMed
Abstract available
Contemporary management of ovarian germ cell tumors and remaining controversies.
Gynecol Oncol. 2020 Jun 4. pii: S0090-8258(20)31075.
PubMed
Abstract available
Reproductive outcomes following fertility-sparing surgery for malignant ovarian
germ cell tumors: A systematic review of the literature.
Gynecol Oncol. 2020 Jun 5. pii: S0090-8258(20)31121.
PubMed
Abstract available
Radiation and hormonal therapy for primary treatment of stage I endometrial
cancer and long-term survival.
Gynecol Oncol. 2020 Jun 16. pii: S0090-8258(20)31088.
PubMed
Abstract available
Aromatase inhibitor use, side effects and discontinuation rates in gynecologic
oncology patients.
Gynecol Oncol. 2020 Aug 23. pii: S0090-8258(20)33816.
PubMed
Abstract available
A preoperative prediction model for predicting coexisting adnexa malignancy of
patients with G1/G2 endometrioid endometrial cancer.
Gynecol Oncol. 2020 Aug 23. pii: S0090-8258(20)33818.
PubMed
Abstract available
Analytic comparison of talc in commercially available baby powder and in pelvic
tissues resected from ovarian carcinoma patients.
Gynecol Oncol. 2020 Sep 22. pii: S0090-8258(20)33921.
PubMed
Abstract available
M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced
ovarian cancer patients.
Gynecol Oncol. 2021 Mar 29. pii: S0090-8258(21)00260.
PubMed
Abstract available
Impact of age, comorbidity, and treatment characteristics on survival in older
women with advanced high grade epithelial ovarian cancer.
Gynecol Oncol. 2021 Mar 31. pii: S0090-8258(21)00228.
PubMed
Abstract available
Gastrointestinal symptoms and diagnosis preceding ovarian cancer diagnosis:
Effects on treatment allocation and potential diagnostic delay.
Gynecol Oncol. 2021 Apr 1. pii: S0090-8258(21)00259.
PubMed
Abstract available
Comparing mutation frequencies for homologous recombination genes in uterine
serous and high-grade serous ovarian carcinomas: A case for homologous
recombination deficiency testing in uterine serous carcinoma.
Gynecol Oncol. 2020 Sep 5. pii: S0090-8258(20)33813.
PubMed
Abstract available
Histological grading of ovarian mucinous carcinoma - an outcome-based analysis of
traditional and novel systems.
Histopathology. 2020;77:26-34.
PubMed
Abstract available
BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong
founder effects.
Int J Cancer. 2020;147:1334-1342.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by